Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Radiolabelled autologous leukocytes have been used for the clinical diagnosis of inflammation and infection. To develop a stable and efficient radiopharmaceutical for labelling leukocytes, we prepared a novel radioiodinated cell-penetrating peptide, 125I-TAT, using a bi-functional linker. 125I-TAT was stable for two days under three different temperature conditions of -20 °C, 4 °C, and 40 °C, with its radiochemical purity remaining over 99%. Iodinated TAT was non-toxic to leukocytes with an IC50 value of over 100 μM. The labelling efficiency of 125I-TAT using 1x107 cells ranged from 27% to 53% when the three leukocyte cell lines were pre-treated with DMSO. This is comparable to the labelling efficiency recommended by the guideline for conventional labelling agents using 2x108 cells. Radioiodinated cell-penetrating peptide may be an improved radiopharmaceutical for white blood cell scans by further optimization. Copyright © 2024 Elsevier Ltd. All rights reserved.

Citation

Byoung Soo Kim, Tae Hyun Choi. Development and evaluation of a radiolabelling agent for white blood cell scans. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 2024 Oct;212:111460

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 39094205

View Full Text